FTW Ventures Research
Investment Thesis
FTW Ventures is a specialized early-stage venture fund focused exclusively on transforming the global Food & Agriculture industries through technology innovation. The fund's mission is to find better ways to feed 10 billion people by 2050 by leveraging 21st-century science and technology to address fundamental inefficiencies in a $12 trillion annual industry that still relies on centuries-old agricultural methods.
Founder Brian Frank brings 20+ years of experience at the intersection of technology and food, having led 3 venture-backed businesses to successful exits and directed innovative products in communication, mobile, social, and AI/ML for both startups and Fortune 500 companies.
Core Values & Investment Philosophy
Modernize: FTW backs disruptive sciences and technology to transform the food system—from biotechnology to help crops grow better, to sensors that detect supply chain issues, to automation that supports farmers, and software that predicts retail demand. The fund believes the future will be built with technology at its core.
Preserve & Amplify: The fund aims to preserve the best of what nature offers while amplifying it—creating more value from soil, water, and nutrients, ensuring system integrity so good food reaches all corners of the world, and achieving better results for human health and happiness.
Nurture: FTW wants to nurture humankind and improve every person's situation in life, recognizing this is good for both business and the world—from rural farmers in the US midwest to tech entrepreneurs in Silicon Valley to individual consumers worldwide.
Stage Focus & Check Size
FTW Ventures primarily focuses on Pre-Seed and Seed stage investments, with selected Series A follow-ons. Based on portfolio analysis:
- Pre-Seed: $500K-$2M investments
- Seed: $1M-$5M investments
- Series A: Selective follow-on participation
Recent investments range from $2.4M to $5.3M, indicating a preference for meaningful checks that allow FTW to be a lead or significant participant in rounds.
Sector & Technology Focus
FTW's investment thesis spans the entire food and agriculture value chain:
Biotechnology & Agricultural Science
- Alternative proteins and sustainable food production
- Plant breeding technologies
- Fermentation and biomanufacturing
- Biological fertilizers and crop optimization
- Engineering biology for food composition
Food Tech & Supply Chain
- Supply chain optimization and software
- Food waste reduction solutions
- Sustainable packaging solutions
- Processing and transformation technologies
- Equipment and machinery innovation
Health & Nutrition
- Nutrition-focused health platforms
- Personalized food interventions
- Eating disorder support and care
- Clinical nutrition management
Infrastructure & Hardware
- Fermentation and bioreactor technology
- Temperature-controlled logistics
- Restaurant and kitchen management software
- Cooking technology and equipment solutions
Recent Activity & Deal Flow
FTW Ventures has been actively deploying capital with 17+ portfolio companies and 3 new investments in the past 12 months (as of mid-2025). Recent notable investments include:
- 2025: FTW participated in People Science's Seed-3 round (led by Acre Ventures, $11M+ raised)
- Early 2024: FTW led the pre-seed for Heritable (spun out from X, Alphabet's Moonshot Factory), with participation from Mythos Ventures and SVG
- 2024: FTW led seed round for Brilliant Harvest ($4M+) with participation from Builders VC and AltaML
- 2023-2024: FTW invested in Izote Biosciences ($2.4M raised) and led seed for Earthodic ($5.3M)
Fund status: Actively deploying Last known activity: Early 2025 (People Science participation)
Portfolio Highlights
Fund I Highlights (Legacy Exits & Growth)
- Geltor - Designer proteins company, raised $116.3M+ (seed investor)
- Spoiler Alert - Supply chain software for food waste, Series A 2021, $11M+ raised
- Plantible Foods - Sustainable plant-based protein, Series A 2021, $21.5M raised
- Debut Biotechnology - Biomanufacturing for high-value molecules, Series B 2021, $32M raised
Fund II Active Portfolio (Growth Stage)
- Boston Bioprocess - Microbial strain evaluation and scale-up
- ALTR - Nanotechnology for alcohol-free beverages ($2.75M raised)
- Sylvan Health - Nutrition navigation platform for health plans (Seed 2023)
- FreshFry - Eco-friendly foodservice filtration (patent-protected)
- Izote Biosciences - Oxygen-free fermentation ($2.4M)
- Arise - Virtual care platform for eating disorders
- Quorum Bio - Biological fertilizers for sustainable farming
- Earthodic - Bio-based sustainable packaging ($5.3M)
- Heritable - AI-driven plant breeding and gene editing
- Brilliant Harvest - AI platform for equipment dealer CX ($4M+)
- Voltair - AI temperature-controlled food logistics platform
- People Science - Decentralized clinical trials platform ($11M+)
Historical Exits
- No exits explicitly mentioned yet (fund still relatively young)
- Strong follow-on investment pattern suggests confidence in portfolio
Team & Network
Core Team:
- Brian Frank (General Partner & Founder): 20+ years in tech and food, led 3 startups to exits, deep experience in mobile, AI/ML, and corporate product innovation
- Jenn Burka (Investor): Former Senior Associate at Evolv Ventures (Kraft Heinz's CVC), culinary operations background
- Tawny Scanlan (Associate, Life Sciences): IIFH Fellow from UC Davis, expertise in sustainable aquaculture and animal biology
- Rob Wilder (Venture Partner): 40-year food industry veteran, co-founder of José Andrés Group and World Central Kitchen, founder of FoodTech Angels
Professional Services Partners:
- NorthMountain Fund Services (Fund Administration)
- Cooley LLP (Fund Formation & Legal)
Decision Process & Investment Criteria
Based on website messaging and portfolio composition:
- Lead tendency: Leads rounds (fund appears in lead/co-lead capacity in most investments)
- Round structure: Acts as lead or significant co-lead on seed/pre-seed rounds
- Team focus: Seeks "crazy ones"—innovators with unique perspectives on food system transformation
- Stage preference: Pre-Seed and Seed, with selective Series A follow-ons
- Technical depth: Co-investors include venture funds specializing in biotech, climate, and agtech
- Industry expertise: Leverages Rob Wilder's 40-year food industry network and Brian Frank's technology experience
Geographic & Co-Investor Patterns
Primary markets: US-based (particularly San Francisco Bay Area, though portfolio spans US and international)
Notable co-investors:
- Acre Ventures (People Science, Spoiler Alert)
- Collaborative Fund (Spoiler Alert)
- Astanor Ventures (Plantible Foods)
- Mythos Ventures (Heritable)
- SVG Ventures (Heritable)
- Max Ventures (Sylvan Health)
- L'Oreal Ventures (Debut Biotech)
- Builders VC (Brilliant Harvest)
- RPV Global (Voltair)
Founder Preferences
Based on portfolio analysis:
- Technical founders with deep domain expertise (biotech, agriculture, supply chain)
- Experienced founders with prior successful exits or achievements
- Teams combining food/ag domain knowledge with technology innovation
- Mission-driven founders focused on sustainability, health, and environmental impact
- Founders willing to navigate the complexity of building at the intersection of biology and software
Investment Challenges & Market Context
FTW explicitly noted in April 2025 that "we did not follow the hype cycle"—indicating the fund took a contrarian approach during the alternative protein boom and subsequent market corrections. This suggests:
- Disciplined approach to sector trends
- Focus on fundamental technology and unit economics over hype
- Confidence in multi-year adoption curves for agricultural innovation
- Selective but committed to the thesis
Notable Recent Developments
- October 2024: Announced Rob Wilder as first Venture Partner, expanding network effects and mentorship capabilities
- 2025: Continued active deployment with focus on climate solutions, sustainable packaging, and life sciences innovation
- Fund trajectory: Multiple exits from Fund I, active deployment of Fund II, indicating successful first fund and strong LP support
Thesis Validation
FTW's thesis that "atoms are harder to move than bits" (quoting Brian Frank's blog post) acknowledges the unique challenge of food & ag tech:
- Hardware/biotech timelines are 18-24 months vs software months
- Manufacturing and supply chain complexity requires different operational support
- The $12T market size provides ample opportunity despite longer development cycles
- Fund positions itself as patient capital for deep tech in the food system
Fund Investment Conviction
The fund demonstrates conviction through:
- Multi-round investments in portfolio companies (Plantible Foods across pre-seed, seed, Series A)
- Strategic partnership with World Central Kitchen and José Andrés Group (via Rob Wilder)
- Focused thesis rather than broad "ag tech" investing
- Selective but committed follow-on strategy
- Integration of industry expertise (Wilder) with technical expertise (Frank, Burka, Scanlan)